Among these hub RBPs, high expression levels of GEMIN7, OAS1, APOBEC3H, and YTHDC1 were associated with favourable prognosis in BLCA patients, while high expression levels of DARS2 and RBMS3 predicted poor prognosis. Here, DARS2 is linked to bladder transitional cell carcinoma.